Understanding how splicing in cells can be regulated and evolved

Structure, regulation, and evolution of the splicing machinery

NIH-funded research University of California Santa Cruz · NIH-11060964

This study is looking at how our cells make important changes to RNA, which can go wrong in diseases like cancer, and aims to find new ways to fix these issues to help improve treatments for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California Santa Cruz NIH-funded
Lab location1 site (Santa Cruz, United States)
Project IDNIH-11060964 on NIH RePORTER

What this research studies

This research investigates the complex process of RNA splicing, which is crucial for gene expression and can be altered in diseases like cancer. The team will explore how specific components of the splicing machinery interact and how these interactions can be engineered to improve treatment outcomes. By using innovative techniques, including RNA sequencing and biochemical tests, the research aims to uncover mechanisms that could lead to new therapeutic strategies for diseases associated with splicing errors.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with genetic disorders or cancers linked to splicing abnormalities.

Not a fit: Patients with conditions unrelated to RNA splicing or those who do not have genetic mutations affecting splicing may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for diseases caused by splicing errors, potentially improving patient outcomes.

How similar studies have performed: Other research has shown promising results in manipulating splicing mechanisms, indicating potential for success in this area.

Where this research is happening

Santa Cruz, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Aran-Duchenne diseasecancer progression
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.